
Japanese pharma giant Takeda has added the title of chief executive to its representative director, president and chief operating officer …

Amgen’s lung cancer drug motesanib has not meet its primary endpoint in a phase III study. The drug, developed in …
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns
How will biomarker-led diagnostics reshape respiratory medicine?

